A carregar...
Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway
There is an urgent need for therapeutic development to combat infections caused by Rift Valley fever virus (RVFV), which causes devastating disease in both humans and animals. In an effort to repurpose drugs for RVFV treatment, our previous studies screened a library of FDA-approved drugs. The most...
Na minha lista:
| Publicado no: | J Virol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5640838/ https://ncbi.nlm.nih.gov/pubmed/28794043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00968-17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|